Certain types of graft-versus-host disease may increase risk of death, researcher says

Joseph Pidala, M.D., M.S., assistant member of the Blood and Bone Marrow Transplant and Immunology programs at Moffitt Cancer Center, and colleagues from the Chronic Graft-Versus-Host Disease Consortium have determined that certain gastrointestinal and liver-related types of chronic graft-versus-host disease (GVHD) are associated with worsened quality of life and death.

Their study appeared in the May issue of Biology of Blood and Marrow Transplantation, the official journal of the American Society for Blood and .

GVHD is a complication that can occur when a transplant patient receives or bone marrow from a donor. The transplanted cells regard the recipient's body as foreign and attack, causing symptoms ranging from nausea and skin rashes to fatigue and pain. Patients with GVHD are prescribed drugs to suppress their immune system to counteract the disease.

The researchers studied data from 567 patients to determine if the characteristics and symptoms of chronic GVHD were associated with major clinical outcomes, such as quality of life and death. They looked specifically at the site of involvement and liver abnormalities.

"We found important differences in outcomes in relation to gastrointestinal and liver involvement," Pidala said. "Those with elevated bilirubin (a substance in bile) levels, higher gastrointestinal scores, or lower gastrointestinal involvement had an increased risk of death under current treatment approaches."

The authors concluded that their findings will help physicians better define a patient's risk of complications and death after chronic GVHD diagnosis and treatment.

add to favorites email to friend print save as pdf

Related Stories

Groundbreaking study that may change transplant practices

Nov 20, 2012

Researchers from John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's 50 best cancer centers, played an important role in a study published in the New England Journal of Medicine on Oct ...

B cell survival holds key to chronic graft vs. host disease

Aug 16, 2012

Leukemia and lymphoma patients who receive life-saving stem cell or bone marrow transplants often experience chronic side effects that significantly decrease quality of life, can last a lifetime, and ultimately affect their ...

Recommended for you

In the battle against Ebola, a double-layer solution

2 hours ago

When working with Ebola patients, protective gear works, but removing it can be harrowing. Seeking to protect health care workers from the precarious nature of taking off soiled gloves, Cornell students have ...

New hope for rare disease drug development

13 hours ago

Using combinations of well-known approved drugs has for the first time been shown to be potentially safe in treating a rare disease, according to the results of a clinical trial published in the open access Orphanet Journal of ...

Three weeks since last Ebola case in Mali: WHO

16 hours ago

Mali has not had a case of Ebola for three weeks, the World Health Organization said Wednesday, completing one of the two incubation periods the country needs to be declared free of the virus.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.